Sign up to save your podcasts
Or
Share 🔬 Silence APOC3, Slash Triglycerides, A New Era in Triglyceride Control
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
🔬 Silence APOC3, Slash Triglycerides, A New Era in Triglyceride Control
🚨 New NEJM Study on Olezarsen 🚨
In patients with moderate hypertriglyceridemia and elevated cardiovascular risk, monthly subcutaneous olezarsen reduced triglycerides by over 60% at 6 months! 📉💥
✅ Significant drops in APOC3, VLDL, remnant & non-HDL cholesterol
✅ No rise in LDL-C
✅ Well-tolerated with mild injection-site reactions
🔬 APOC3 inhibition emerges as a game-changer in lipidology.
📖 ESSENCE–TIMI 73b Trial | Funded by Ionis Pharmaceuticals
#Cardiology #LipidLowering #PrecisionMedicine #NEJM #Olezarsen #TGlowering #CVRisk #TIMI #Atherosclerosis #GenomicTherapy 🧬💊🫀
View all episodes
By Dr RR Baliga, MD, MBA
5
66 ratings
🚨 New NEJM Study on Olezarsen 🚨
In patients with moderate hypertriglyceridemia and elevated cardiovascular risk, monthly subcutaneous olezarsen reduced triglycerides by over 60% at 6 months! 📉💥
✅ Significant drops in APOC3, VLDL, remnant & non-HDL cholesterol
✅ No rise in LDL-C
✅ Well-tolerated with mild injection-site reactions
🔬 APOC3 inhibition emerges as a game-changer in lipidology.
📖 ESSENCE–TIMI 73b Trial | Funded by Ionis Pharmaceuticals
#Cardiology #LipidLowering #PrecisionMedicine #NEJM #Olezarsen #TGlowering #CVRisk #TIMI #Atherosclerosis #GenomicTherapy 🧬💊🫀
More shows like Dr RR Baliga's "Got Knowledge Doc" Podkast
View all
This Week in Cardiology
893 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
The Mel Robbins Podcast
21,500 Listeners